Carlsmed, Inc. (CARL)

Carlsmed Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2024	Dec 31, 2023
Cash & Equivalents	43.53	40.23	7.37
Cash & Cash Equivalents	43.53	40.23	7.37
Cash Growth	-	445.65%	-
Receivables	8.12	6.77	3.17
Inventory	1.26	1	0.58
Other Current Assets	1.27	1.37	0.65
Total Current Assets	54.18	49.35	11.77
Property, Plant & Equipment	-	0.26	0.23
Goodwill and Intangibles	-	1.64	2.02
Other Long-Term Assets	-	0.57	0.02
Total Long-Term Assets	-	2.47	2.26
Total Assets	-	51.82	14.02
Accounts Payable	-	2.41	1.69
Current Debt	-	0.45	2.15
Other Current Liabilities	8.36	5.96	3.6
Total Current Liabilities	8.36	8.82	7.44
Long-Term Debt	-	16.73	9.24
Other Long-Term Liabilities	-	0.68	0.1
Total Long-Term Liabilities	-	17.41	9.34
Total Liabilities	-	26.23	16.78
Total Debt	17.08	17.18	11.39
Debt Growth	-	50.87%	-
Retained Earnings	-	-71.17	-46.91
Shareholders' Equity	-76.61	-70.63	-46.13
Net Cash (Debt)	26.45	23.05	-4.02
Working Capital	45.82	40.53	4.33

Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).